12:08 PM EDT, 10/24/2024 (MT Newswires) -- (Updates to include stock's movement in the headline and first paragraph.)

West Pharmaceutical Services ( WST ) shares jumped 17% in recent Thursday trading after the company posted Q3 results that topped estimates by analysts and raised 2024 adjusted EPS guidance

Adjusted earnings in the three months ended Sept. 30 fell to $1.85 per diluted share from $2.16 a year earlier, the company said Thursday in a statement.

Analysts polled by Capital IQ expected $1.49.

Revenue dropped $746.9 million from $747.4 million a year earlier.

Analysts surveyed by Capital IQ expected $709.6 million.

The company increased 2024 adjusted EPS guidance to the range of $6.55 to $6.75 on revenue of $2.88 billion to $2.91 billion. The previous outlook was for EPS of $6.35 to $6.65 on revenue of 2.87 billion to $2.9 billion.

Analysts polled by Capital IQ expect EPS of $6.41 on revenue of $2.87 billion.

Price: 335.46, Change: +49.02, Percent Change: +17.11